Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | A worker inspects labels on vials containing H5N1 flu vaccine during production. (Andy Wong/AP) | | | | | | |  What to know Moderna is conducting a large-scale trial for a bird flu vaccine using mRNA technology after the Department of Health and Human Services previously pulled funding, citing concerns over mRNA’s effectiveness against mutating viruses. Moderna’s CEO calls the trial a milestone for global pandemic preparedness. Summary is AI-generated, newsroom-reviewed. | | | | Opinion Letters to the Editor | | | Column Judith Martin, Nicholas Martin and Jacobina Martin | | | Opinion Elena McGovern and Daniel Silverberg | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
